Article info
Research Article
Moral assessment of growth hormone therapy for children with idiopathic short stature.
Citation
Moral assessment of growth hormone therapy for children with idiopathic short stature.
Publication history
- First published October 1, 1997.
Online issue publication
October 01, 1997
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature
- Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review
- Why give a child growth hormone?
- Indications for growth hormone therapy in children
- Metacarpal index in short stature before and during growth hormone treatment
- How sociophenomenology of the body problematises the ‘problem-oriented approach’ to growth hormone treatment
- Vitamin D status in prepubertal children with isolated idiopathic growth hormone deficiency: effect of growth hormone therapy
- Growth hormone insensitivity: a widening diagnosis
- Measuring the benefits of growth hormone therapy in children: a role for preference-based approaches?
- How to use insulin-like growth factor 1 (IGF1)